For opened pens, store them just like you would at home
GLP-1 Companion Products Market Overview, Growth Outlook, and Forecast by Fact.MR In 2025, the global GLP-1 companion products market was valued at approximately USD 4.7 billion
As mentioned previously, liraglutide, dulaglutide, albiglutide, and semaglutide have been shown to reduce the risk of cardiovascular events in patients with diabetes and either established ASCVD or high-risk characteristics in randomized controlled trials [35, 36, 49]
Your prescribed GLP-1 medication, or any other weight loss medication, will be sent to an associate compounding pharmacy licensed in your state
Iron deficiency is perhaps the most significant